{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:47:06Z","timestamp":1789685226115,"version":"4.0.1"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T00:00:00Z","timestamp":1436486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0132722","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T18:28:20Z","timestamp":1436552900000},"page":"e0132722","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3\u03b2 Signalling Pathways in Rats"],"prefix":"10.1371","volume":"10","author":[{"given":"Bo","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiezhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/138161210790361461","article-title":"Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?","volume":"16","author":"RB Mailman","year":"2010","journal-title":"Curr Pharm Des"},{"key":"ref2","first-page":"CD006569","article-title":"Aripiprazole versus other atypical antipsychotics for schizophrenia","volume":"2","author":"P Khanna","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2152\/jmi.52.284","article-title":"Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist","volume":"52","author":"T Hirose","year":"2005","journal-title":"J Med Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"KD Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.npp.1301071","article-title":"Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways","volume":"32","author":"JD Urban","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"JD Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2007.06.002","article-title":"GPCR functional selectivity has therapeutic impact","volume":"28","author":"RB Mailman","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"CP Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"DA Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","article-title":"7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinon e (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity","volume":"274","author":"T Kikuchi","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1017\/S1461145709009948","article-title":"Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects","volume":"12","author":"M Han","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0306-4522(97)00510-1","article-title":"Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons","volume":"84","author":"P Svenningsson","year":"1998","journal-title":"Neuroscience"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nn.2153","article-title":"Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs","volume":"11","author":"HS Bateup","year":"2008","journal-title":"Nat Neurosci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.294.5544.1024","article-title":"The neurobiology of slow synaptic transmission","volume":"294","author":"P Greengard","year":"2001","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"P Seeman","year":"2010","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1471-4159.1987.tb13153.x","article-title":"Activation of tyrosine hydroxylase in PC12 cells by the cyclic GMP and cyclic AMP second messenger systems","volume":"48","author":"R Roskoski Jr.","year":"1987","journal-title":"J Neurochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1471-4159.1996.67020629.x","article-title":"Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme","volume":"67","author":"Harada","year":"1996","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-4159.1986.tb00775.x","article-title":"Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals?","volume":"47","author":"S el Mestikawy","year":"1986","journal-title":"J Neurochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0026-895X(25)10283-6","article-title":"Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase","volume":"29","author":"KA Strait","year":"1986","journal-title":"Mol Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1523\/JNEUROSCI.18-24-10304.1998","article-title":"Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine","volume":"18","author":"M Batchelor","year":"1998","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuint.2004.04.002","article-title":"The up-regulation of the striatal dopamine transporter's activity by cAMP is PKA-, CaMK II- and phosphatase-dependent","volume":"45","author":"G Page","year":"2004","journal-title":"Neurochem Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00702-010-0396-5","article-title":"Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats","volume":"117","author":"T Der-Ghazarian","year":"2010","journal-title":"J Neural Transm"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuroimage.2005.11.014","article-title":"Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge","volume":"30","author":"I Vernaleken","year":"2006","journal-title":"Neuroimage"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"ES Emamian","year":"2004","journal-title":"Nat Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tins.2007.02.002","article-title":"Schizophrenia as a GSK-3 dysregulation disorder","volume":"30","author":"S Lovestone","year":"2007","journal-title":"Trends Neurosci"},{"key":"ref26","first-page":"16","article-title":"Glycogen synthase kinase-3 in the etiology and treatment of mood disorders","volume":"4","author":"RS Jope","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(00)00174-2","article-title":"Low GSK-3 activity in frontal cortex of schizophrenic patients","volume":"52","author":"N Kozlovsky","year":"2001","journal-title":"Schizophr Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1358\/dnp.2007.20.7.1149632","article-title":"The role of glycogen synthase kinase-3beta in schizophrenia","volume":"20","author":"E Koros","year":"2007","journal-title":"Drug News Perspect"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(01)01688-3","article-title":"Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia","volume":"302","author":"C Beasley","year":"2001","journal-title":"Neurosci Lett"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","article-title":"Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo","volume":"27","author":"JM Beaulieu","year":"2007","journal-title":"J Neurosci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"JM Beaulieu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"JM Beaulieu","year":"2005","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1073\/pnas.1104807108","article-title":"Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy","volume":"108","author":"JA Allen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2008.09.008","article-title":"Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors","volume":"597","author":"Y Tadori","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2007.07.031","article-title":"Differences in agonist\/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208\u2013912","volume":"574","author":"Y Tadori","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"ref36","first-page":"443","article-title":"Disposition and metabolism of [14C]-haloperidol in rats","volume":"36","author":"H Miyazaki","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchromb.2005.03.024","article-title":"High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study","volume":"821","author":"Y Shimokawa","year":"2005","journal-title":"Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences"},{"key":"ref38","article-title":"International Congress on Schizophrenia Research","author":"D Malling","year":"2007"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psyneuen.2014.01.018","article-title":"Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats","volume":"42","author":"M He","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pnpbp.2014.02.003","article-title":"Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats","volume":"51","author":"Q Zhang","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S1461145713001697","article-title":"Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats","volume":"17","author":"Q Zhang","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref42","article-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"2005"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0896-6273(89)90116-5","article-title":"Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain","volume":"3","author":"G Cadd","year":"1989","journal-title":"Neuron"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"15360","DOI":"10.1016\/S0021-9258(18)66717-1","article-title":"Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase","volume":"261","author":"MD Uhler","year":"1986","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1074\/jbc.271.3.1638","article-title":"Promoter sequences in the RI beta subunit gene of cAMP-dependent protein kinase required for transgene expression in mouse brain","volume":"271","author":"CH Clegg","year":"1996","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e60935","DOI":"10.1371\/journal.pone.0060935","article-title":"Evolutionary paths of the cAMP-dependent protein kinase (PKA) catalytic subunits","volume":"8","author":"K Soberg","year":"2013","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1016\/S0021-9258(18)45175-7","article-title":"Inhibition of intracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit","volume":"262","author":"CH Clegg","year":"1987","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neubiorev.2004.05.001","article-title":"The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems","volume":"28","author":"A Adell","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1073\/pnas.88.5.1859","article-title":"D1 and D2 dopamine receptor mRNA in rat brain","volume":"88","author":"DM Weiner","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35041572","article-title":"Distinct functions of the two isoforms of dopamine D2 receptors","volume":"408","author":"A Usiello","year":"2000","journal-title":"Nature"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.2042-7158.1985.tb04994.x","article-title":"Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra","volume":"37","author":"H Nissbrandt","year":"1985","journal-title":"J Pharm Pharmacol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1749-6632.1990.tb32003.x","article-title":"Autoreceptor regulation of dopamine synthesis","volume":"604","author":"ME Wolf","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.pharmtox.39.1.313","article-title":"New insights into dopaminergic receptor function using antisense and genetically altered animals","volume":"39","author":"DR Sibley","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of Chlorpromazine or Haloperidol on Formation of 3methoxytyramine and Normetanephrine in Mouse Brain","volume":"20","author":"A Carlsson","year":"1963","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1146\/annurev.bi.59.070190.004543","article-title":"cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes","volume":"59","author":"SS Taylor","year":"1990","journal-title":"Annu Rev Biochem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-642-25761-2_3","article-title":"Dopamine receptor signaling and current and future antipsychotic drugs","author":"KN Boyd","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"Suppl","key":"ref57","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1016\/0197-0186(92)90217-F","article-title":"Presynaptic dopamine autoreceptors and second messengers controlling tyrosine hydroxylase activity in rat brain","volume":"20","author":"P Onali","year":"1992","journal-title":"Neurochem Int"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","article-title":"Dopamine partial agonists: a new class of antipsychotic","volume":"18","author":"JA Lieberman","year":"2004","journal-title":"CNS Drugs"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"B Masri","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0952-3278(92)90059-R","article-title":"Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo","volume":"46","author":"M Kaneko","year":"1992","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2003.11.059","article-title":"Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice","volume":"357","author":"AV Turalba","year":"2004","journal-title":"Neurosci Lett"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.301.1.197","article-title":"Differential effects of haloperidol and clozapine on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain","volume":"301","author":"Y Dwivedi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00182999","article-title":"Effects of the partial dopamine receptor agonists SDZ 208\u2013911, SDZ 208\u2013912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study","volume":"344","author":"K Svensson","year":"1991","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fnmol.2012.00033","article-title":"AKT\/GSK3 signaling pathway and schizophrenia","volume":"5","author":"ES Emamian","year":"2012","journal-title":"Front Mol Neurosci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.biopsych.2004.11.036","article-title":"Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum","volume":"57","author":"H Alimohamad","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.2005.03388.x","article-title":"The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats","volume":"95","author":"H Alimohamad","year":"2005","journal-title":"J Neurochem"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","article-title":"Akt\/GSK3 signaling in the action of psychotropic drugs","volume":"49","author":"JM Beaulieu","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1461145706006547","article-title":"Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics","volume":"10","author":"X Li","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.biopsych.2007.06.005","article-title":"AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families","volume":"63","author":"DL Thiselton","year":"2008","journal-title":"Biol Psychiatry"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00213-014-3608-0","article-title":"The activation of the Akt\/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect","volume":"231","author":"GC Smith","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"20732","DOI":"10.1073\/pnas.1215489109","article-title":"Deletion of GSK3beta in D2R-expressing neurons reveals distinct roles for beta-arrestin signaling in antipsychotic and lithium action","volume":"109","author":"NM Urs","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0306-4522(01)00511-5","article-title":"Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development","volume":"109","author":"EV Gurevich","year":"2002","journal-title":"Neuroscience"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-5793(04)00082-1","article-title":"The effects of clozapine on the GSK-3-mediated signaling pathway","volume":"560","author":"UG Kang","year":"2004","journal-title":"FEBS Lett"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-4159.2007.04527.x","article-title":"Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3","volume":"102","author":"LP Sutton","year":"2007","journal-title":"J Neurochem"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neures.2011.08.010","article-title":"Effects of antipsychotic drugs on BDNF, GSK-3beta, and beta-catenin expression in rats subjected to immobilization stress","volume":"71","author":"SW Park","year":"2011","journal-title":"Neurosci Res"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability","volume":"26","author":"A DeLeon","year":"2004","journal-title":"Clin Ther"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cellsig.2011.09.009","article-title":"Functional significance of glycogen synthase kinase-3 regulation by serotonin","volume":"24","author":"AM Polter","year":"2012","journal-title":"Cell Signal"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.neuroscience.2009.09.041","article-title":"The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain","volume":"164","author":"M Han","year":"2009","journal-title":"Neuroscience"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1017\/S1461145709000327","article-title":"The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics","volume":"12","author":"R Mizrahi","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568007024606195","article-title":"Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis","volume":"1","author":"CA Tamminga","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"JM Beaulieu","year":"2007","journal-title":"Trends Pharmacol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0132722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T03:51:27Z","timestamp":1748490687000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0132722"}},"subtitle":[],"editor":[{"given":"Consuelo","family":"Walss-Bass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,10]]},"references-count":81,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0132722","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,10]]}}}